JPH0928671A - Blood sugar measuring device using natural fluorescence from the cornea - Google Patents

Blood sugar measuring device using natural fluorescence from the cornea

Info

Publication number
JPH0928671A
JPH0928671A JP7207737A JP20773795A JPH0928671A JP H0928671 A JPH0928671 A JP H0928671A JP 7207737 A JP7207737 A JP 7207737A JP 20773795 A JP20773795 A JP 20773795A JP H0928671 A JPH0928671 A JP H0928671A
Authority
JP
Japan
Prior art keywords
natural fluorescence
cornea
fluorescence
excitation light
blood glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7207737A
Other languages
Japanese (ja)
Other versions
JP3580607B2 (en
Inventor
Akitoshi Yoshida
晃敏 吉田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP20773795A priority Critical patent/JP3580607B2/en
Publication of JPH0928671A publication Critical patent/JPH0928671A/en
Application granted granted Critical
Publication of JP3580607B2 publication Critical patent/JP3580607B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Eye Examination Apparatus (AREA)

Abstract

PROBLEM TO BE SOLVED: To enable non-invasive blood sugar measuring making use of natural fluorescence from the eyeball. SOLUTION: An optical system 2 concentrates an excitation light with its wavelength selected from the visible to near infrared range upon the cornea, and the natural fluorescence emitted by the cornea under excitation light irradiation is detected. An arithmetic operation unit 4, which keeps in storage the relationship between the blood sugar fluctuation and the fluctuation in natural fluorescence from the cornea, outputs a blood sugar fluctuation on the basis of the deviation of the natural fluorescence detected by the optical system 2 from the stored value of natural fluorescence.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は血糖値を非侵襲で測
定する装置に関するものである。
TECHNICAL FIELD The present invention relates to a device for non-invasively measuring blood glucose level.

【0002】[0002]

【従来の技術】血糖値の測定は糖尿病の病状診断や病後
管理の重要な指標となるため、従来から種々の測定法が
開発されている。現在では酵素法が中心であが、o−ト
ルイジン−ホウ酸(o−TB)法を初め、種々の方法が
行われている。しかし、いずれの方法もその都度採血を
必要として患者に苦痛を与え、また検査に手間がかか
る。
2. Description of the Related Art Since the measurement of blood glucose level is an important index for diagnosing the condition of diabetes and post-morbid management, various measuring methods have been developed. At present, the enzyme method is mainly used, but various methods such as the o-toluidine-boric acid (o-TB) method have been carried out. However, each method requires blood sampling each time, causing pain to the patient and laborious examination.

【0003】本発明者は、眼球に可視から近赤外領域の
間の選択された波長の励起光を照射し、ガラス体や水晶
体からの自然螢光を測定して糖尿病患者と正常人との間
で有意の差があることを報告している(臨眼,38(10) :
1059-1064, (1984) 参照)。眼球からの蛍光の測定
は、fluorescein-Naを静脈に注射した後に行なうのが一
般的であるが、自然蛍光はfluorescein-Naを静脈注射し
ないで測定された蛍光である。
The inventor of the present invention irradiates the eye with excitation light of a selected wavelength in the visible to near-infrared region, and measures natural fluorescence from the glass body and the crystalline lens to measure the diabetic patient and the normal person. It reported that there was a significant difference between the two (Inai, 38 (10):
1059-1064, (1984)). The fluorescence from the eyeball is generally measured after intravenous injection of fluorescein-Na, but the natural fluorescence is the fluorescence measured without intravenous injection of fluorescein-Na.

【0004】[0004]

【発明が解決しようとする課題】しかし、眼球の種々の
場所からの自然蛍光と血糖値の相関関係については、今
までのところ知見は得られていなかった。本発明は眼球
からの自然蛍光を利用して血糖値を非侵襲で測定できる
ようにすることを目的とするものである。
However, so far no knowledge has been obtained regarding the correlation between natural fluorescence from various places on the eyeball and blood glucose level. An object of the present invention is to enable blood glucose level to be measured non-invasively using natural fluorescence from the eyeball.

【0005】[0005]

【課題を解決するための手段】本発明者は、眼球からの
自然蛍光のうち、角膜自然蛍光の変動値が血糖値の変動
値と相関のあることを見出し、本発明を出すに至った。
すなわち、本発明は図1に示されるように、可視から近
赤外領域の間の選択された波長の励起光を角膜に集光さ
せ、その励起光による角膜からの自然蛍光を検出する光
学系2と、血糖変動値と角膜自然蛍光変動値との関係を
保持しておき、光学系2による角膜自然蛍光検出値の変
動値に基づいて血糖変動値を出力する演算部4とを備え
て、血糖値を非侵襲で測定できるようにした装置であ
る。
The present inventor has found that, out of the natural fluorescence from the eyeball, the fluctuation value of the corneal natural fluorescence correlates with the fluctuation value of the blood glucose level, and has reached the present invention.
That is, according to the present invention, as shown in FIG. 1, an optical system that collects excitation light of a selected wavelength in the visible to near-infrared region on the cornea and detects natural fluorescence from the cornea due to the excitation light. 2, and a calculation unit 4 that holds the relationship between the blood glucose fluctuation value and the corneal natural fluorescence fluctuation value, and outputs the blood sugar fluctuation value based on the fluctuation value of the corneal natural fluorescence detection value by the optical system 2. It is a device that enables non-invasive measurement of blood glucose level.

【0006】インスリン非依存型糖尿病における増殖糖
尿病網膜症(PDR)患者16名について同一の日の異
なった時刻に角膜自然蛍光値と採血法による血糖値とを
2回測定し、図2に示される血糖変動値と角膜自然蛍光
変動値の関係を得た。これらのデータは相関係数r=
0.648、p<0.01(pは危険率)の結果を示し、
有意な正の相関を示している。図2に示されるような相
関関係が演算部4に記憶されている。一方、同時に測定
した血糖変動値と水晶体自然蛍光変動値との間には、図
3に示されるように、有意な相関は認められなかった。
[0006] For 16 patients with proliferative diabetic retinopathy (PDR) in non-insulin-dependent diabetes mellitus, the spontaneous corneal fluorescence value and the blood glucose level by blood sampling were measured twice at different times on the same day, and are shown in FIG. The relationship between blood glucose fluctuation and corneal natural fluorescence fluctuation was obtained. The correlation coefficient r =
The result of 0.648, p <0.01 (p is a risk rate) is shown.
It shows a significant positive correlation. The correlation as shown in FIG. 2 is stored in the calculation unit 4. On the other hand, as shown in FIG. 3, no significant correlation was observed between the blood glucose fluctuation value and the lens natural fluorescence fluctuation value measured at the same time.

【0007】角膜自然蛍光から得られるのは血糖値の絶
対値ではなく変動値であるので、絶対値を求めるために
は、各患者について従来の採血による血糖値測定値とそ
のときの角膜自然蛍光検出値とを測定して基準値として
記憶させておき、その後の角膜自然蛍光検出値とその基
準値との差として角膜自然蛍光変動値を求め、それに対
応する血糖変動値を求め、それを血糖値基準値と比較す
ることによって各時点での絶対血糖値を求めることがで
きる。
[0007] Since it is not the absolute value of the blood glucose level that is obtained from the corneal natural fluorescence, but the absolute value, it is necessary to obtain the absolute value by measuring the blood glucose level of each patient by conventional blood sampling and the corneal natural fluorescence at that time. The detected value is measured and stored as a reference value, and the corneal natural fluorescence fluctuation value is calculated as the difference between the subsequent corneal natural fluorescence detection value and the reference value, and the corresponding blood glucose fluctuation value is calculated, and the blood glucose fluctuation value is calculated. The absolute blood glucose level at each time point can be obtained by comparing with the value reference value.

【0008】[0008]

【実施例】図4と図5より角膜自然蛍光値を測定する光
学系の一例を説明する。図4は可視から近赤外領域の間
の選択された波長の励起光を角膜に照射し、その励起光
による角膜からの自然蛍光を検出する光学系を表わした
ものである。角膜からの蛍光も選択的に検出できるよう
にするために、図4の光学系に図5に示す前眼部蛍光測
定用アダプターを装着し、眼軸に沿った所定の深さの位
置での蛍光を計測できるようにしている。
EXAMPLE An example of an optical system for measuring a natural corneal fluorescence value will be described with reference to FIGS. FIG. 4 shows an optical system for irradiating the cornea with excitation light having a selected wavelength in the visible to near-infrared region and detecting natural fluorescence from the cornea due to the excitation light. In order to detect fluorescence from the cornea selectively, the anterior ocular segment fluorescence measurement adapter shown in FIG. 5 is attached to the optical system of FIG. 4, and the optical system of FIG. The fluorescence can be measured.

【0009】光軸10に沿って固定レンズ12と走査レ
ンズ14が配置されており、光軸10の走査レンズ14
側の延長線上に被検体である眼球16がその眼軸が光軸
10と一致するように配置される。光軸10上に設けら
れたレンズ18と眼球16の間には図4に示されるアダ
プター20が配置されている。
A fixed lens 12 and a scanning lens 14 are arranged along the optical axis 10, and the scanning lens 14 of the optical axis 10 is arranged.
The eyeball 16 which is the subject is arranged on the extension line on the side such that its eye axis coincides with the optical axis 10. An adapter 20 shown in FIG. 4 is arranged between the lens 18 and the eyeball 16 provided on the optical axis 10.

【0010】眼球16に励起光を照射するために、励起
光源22としてタングステンランプが設けられ、光源2
2からの連続波長光から所定波長光を励起光として取り
出すフィルタ24、及び励起光を小さい系の光束とする
スリット26を介して、所定波長で細く絞られた励起光
28がミラー30で反射されてレンズ12,14に入射
する。レンズ12,14で集光された励起光28は、レ
ンズ18からアダプタ20を経て眼球の所定の深さの位
置に集光されるようになっている。走査レンズ14を光
軸に沿って移動させることにより、励起光28が集光さ
れる深さ位置が眼軸に沿って移動する。ここでは、特に
励起光28が角膜に集光される。
A tungsten lamp is provided as the excitation light source 22 in order to irradiate the eyeball 16 with the excitation light.
The excitation light 28 that is narrowed down at the predetermined wavelength is reflected by the mirror 30 through the filter 24 that extracts the predetermined wavelength light as the excitation light from the continuous-wave light from 2 and the slit 26 that makes the excitation light a light flux of a small system. Incident on the lenses 12, 14. The excitation light 28 condensed by the lenses 12 and 14 is adapted to be condensed from the lens 18 through the adapter 20 to a position of a predetermined depth of the eyeball. By moving the scanning lens 14 along the optical axis, the depth position where the excitation light 28 is focused moves along the eye axis. Here, in particular, the excitation light 28 is focused on the cornea.

【0011】励起光照射により眼球16から発生した蛍
光を検出するために、光軸16上で固定レンズ12側の
延長線上には検出器スリット32、バリアフィルタ34
を経て光電子増倍管(PMT)36が配置されている。
患者の眼球16の眼軸が光軸10と一致するように、光
軸10上にターゲット用の光を発生する眼軸固定用ター
ゲット光源38が設けられ、その光がスリット40を経
てビーム状になり、ビームスプリッタ41によって光軸
10上に入射する。
In order to detect the fluorescence generated from the eyeball 16 by the irradiation of the excitation light, the detector slit 32 and the barrier filter 34 are provided on the extension line of the fixed lens 12 side on the optical axis 16.
After that, a photomultiplier tube (PMT) 36 is arranged.
An eye-axis fixing target light source 38 that emits light for a target is provided on the optical axis 10 so that the eye axis of the patient's eyeball 16 coincides with the optical axis 10, and the light passes through the slit 40 to form a beam. And enters the optical axis 10 by the beam splitter 41.

【0012】オペレータが患者の眼の位置を確認するた
めに、光軸10と直交する光軸上にスプリットスクリー
ン42及びレンズ44を介して患者アライメントポート
46が配置されており、患者アライメントポート46用
の光軸と光軸10との交点にはミラー48が着脱可能に
装着される。ミラー48が光軸10を横切るように配置
されたときに患者アライメントポート46から患者の眼
球16を確認することができる。
In order for the operator to confirm the position of the patient's eye, a patient alignment port 46 is arranged on the optical axis orthogonal to the optical axis 10 via a split screen 42 and a lens 44. A mirror 48 is detachably attached to the intersection of the optical axis of the optical axis 10 and the optical axis 10. The patient's eye 16 can be seen through the patient alignment port 46 when the mirror 48 is positioned across the optical axis 10.

【0013】また、光源の強度による検出値の補正を行
なうために、ミラー48と一体的に組み立てられた校正
用ガラス面50が設けられており、ミラー48が光軸1
0を横切る位置に配置されたときにそのガラス面50も
光軸10上に配置され、光源22からの励起光がそのガ
ラス面50で反射して検出器36へ入射し、光源強度が
検出されるようになっている。
Further, in order to correct the detected value by the intensity of the light source, a calibration glass surface 50 assembled integrally with the mirror 48 is provided, and the mirror 48 is provided with the optical axis 1.
When the glass surface 50 is arranged at a position crossing 0, the glass surface 50 is also arranged on the optical axis 10, and the excitation light from the light source 22 is reflected by the glass surface 50 and enters the detector 36, and the light source intensity is detected. It has become so.

【0014】[0014]

【発明の効果】本発明では採血法による血糖値と角膜自
然蛍光値との関係を各患者について1度だけ測定してお
けば、その後は角膜自然蛍光値を測定するだけで血糖値
を非侵襲で求めることができる。そのため、糖尿病患者
の病状判定や監視を容易に、かつ短時間に行なうことが
できるようになる。
According to the present invention, the relationship between the blood glucose level by the blood sampling method and the natural corneal fluorescence value is measured once for each patient, and thereafter the blood glucose level is non-invasive only by measuring the natural corneal fluorescence value. Can be found at. Therefore, it becomes possible to easily perform the disease state determination and monitoring of the diabetic patient in a short time.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明を示すブロック図である。FIG. 1 is a block diagram illustrating the present invention.

【図2】本発明における血糖変動値と角膜自然蛍光変動
値との相関関係を示す図である。
FIG. 2 is a diagram showing a correlation between a blood glucose fluctuation value and a corneal natural fluorescence fluctuation value in the present invention.

【図3】比較例として、血糖変動値と水晶体自然蛍光変
動値との相関関係を示す図である。
FIG. 3 is a diagram showing a correlation between a blood glucose fluctuation value and a lens natural fluorescence fluctuation value as a comparative example.

【図4】一実施例で用いた光学系を示す概略構成図であ
る。
FIG. 4 is a schematic configuration diagram showing an optical system used in an example.

【図5】同実施例の光学系におけるアダプタを示す概略
構成図である。
FIG. 5 is a schematic configuration diagram showing an adapter in the optical system of the same example.

【符号の説明】[Explanation of symbols]

2 光学系 4 演算部 2 Optical system 4 Calculation unit

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 可視から近赤外領域の間の選択された波
長の励起光を角膜に集光させ、その励起光による角膜か
らの自然蛍光を検出する光学系と、 血糖変動値と角膜自然蛍光変動値との関係を保持してお
き、前記光学系による角膜自然蛍光検出値の変動値に基
づいて血糖変動値を出力する演算部と、を備えたことを
特徴とする非侵襲の血糖値測定装置。
1. An optical system for concentrating excitation light of a selected wavelength in the visible to near-infrared region on the cornea and detecting natural fluorescence from the cornea due to the excitation light, blood glucose fluctuation value and corneal naturalness. A non-invasive blood glucose level, which holds a relationship with a fluorescence variation value, and an arithmetic unit which outputs a blood glucose variation value based on the variation value of the corneal natural fluorescence detection value by the optical system. measuring device.
JP20773795A 1995-07-22 1995-07-22 Blood glucose measurement device using corneal natural fluorescence Expired - Lifetime JP3580607B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20773795A JP3580607B2 (en) 1995-07-22 1995-07-22 Blood glucose measurement device using corneal natural fluorescence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20773795A JP3580607B2 (en) 1995-07-22 1995-07-22 Blood glucose measurement device using corneal natural fluorescence

Publications (2)

Publication Number Publication Date
JPH0928671A true JPH0928671A (en) 1997-02-04
JP3580607B2 JP3580607B2 (en) 2004-10-27

Family

ID=16544710

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20773795A Expired - Lifetime JP3580607B2 (en) 1995-07-22 1995-07-22 Blood glucose measurement device using corneal natural fluorescence

Country Status (1)

Country Link
JP (1) JP3580607B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014023830A (en) * 2012-07-30 2014-02-06 Nidek Co Ltd Fundus imaging device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014023830A (en) * 2012-07-30 2014-02-06 Nidek Co Ltd Fundus imaging device

Also Published As

Publication number Publication date
JP3580607B2 (en) 2004-10-27

Similar Documents

Publication Publication Date Title
JP2736002B2 (en) Device for in vivo measurement of optical properties of aqueous humor of the eye
US6305804B1 (en) Non-invasive measurement of blood component using retinal imaging
CA2718938C (en) Ocular imaging
US5582168A (en) Apparatus and methods for measuring characteristics of biological tissues and similar materials
US7828436B2 (en) Ocular imaging
EP0792619B1 (en) Blood glucose measurement apparatus
EP0225072B1 (en) Ophthalmic disease detection apparatus
US4950068A (en) Ophthalmic disease detection apparatus
US6347242B1 (en) Apparatus for measuring occular choroidal blood flow
EP3547895B1 (en) Visualization systems and methods for optimized optical coherence tomography
JP2520426B2 (en) Ophthalmic measuring device
JP3580607B2 (en) Blood glucose measurement device using corneal natural fluorescence
WO2001078589A1 (en) Non-invasive measurement of blood components using retinal imaging
Lompado et al. Multispectral confocal scanning laser ophthalmoscope for retinal vessel oximetry
JP3318379B2 (en) Ophthalmic measurement device
EP0296733B1 (en) Ophthalmic disease detection apparatus
Eppstein et al. Noninvasive detection of diabetes mellitus
JPH0523302A (en) Optometric apparatus
JPH0332637A (en) Handy eye refractometer
JP3181893B2 (en) Eye refractometer
JP2001000394A (en) Optometrical device
JPS63279822A (en) Ophthalmic measuring apparatus
JPH04256725A (en) Ophthalmic device

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040114

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040120

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040322

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040720

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040720

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080730

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090730

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090730

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100730

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100730

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110730

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120730

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120730

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130730

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term